Business

Announcement on Voluntary Disclosure of Release of Relevant Data of APL-1702 International Multicenter Phase III Clinical Trial at the 27th National Conference on Clinical Oncology and 2024 Annual Meeting of Chinese Society of Clinical Oncology

Announcement on Voluntary Disclosure of Release of Relevant Data of APL-1702 International Multicenter Phase III Clinical Trial at the 27th National Conference on Clinical Oncology and 2024 Annual Meeting of Chinese Society of Clinical Oncology

articleJiangsu Yahong Meditech Co., Ltd. Class ASeptember 27, 20245/news/announcement-on-voluntary-disclosure-of-release-of-relevant-data-of-apl-1702-international-multicenter-phase-iii-clinical-trial-at-the-27th-national-conference-on-clinical-oncology-and-2024-annual-meeting-of-chinese-society-of-clinical-oncology
Announcement on Voluntary Disclosure of Release of Relevant Data of APL-1702 International Multicenter Phase III Clinical Trial at the 27th National Conference on Clinical Oncology and 2024 Annual Meeting of Chinese Society of Clinical Oncology

About this update from Jiangsu Yahong Meditech Co., Ltd. Class A

Announcement on Voluntary Disclosure of Release of Relevant Data of APL-1702 International Multicenter Phase III Clinical Trial at the 27th National Conference on Clinical Oncology and 2024 Annual Meeting of Chinese Society of Clinical OncologyThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Jiangsu Yahong Meditech Co., Ltd. Class A